Published in

Wiley, Clinical and Experimental Dermatology, 12(47), p. 2284-2285, 2022

DOI: 10.1111/ced.15354

Links

Tools

Export citation

Search in Google Scholar

CDKN2A exon 1B deletion predisposing to melanoma and neural system tumour syndrome

Journal article published in 2022 by Samantha L. Wong ORCID, Daniela Martiniuc, Maija Kiuru ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Abstract CDKN2A at chromosome positon 9p21 is a tumour suppressor gene encoding the cell cycle regulators p16 and p14ARF. While melanoma is associated with variants affecting both transcripts, families with mutations involving the p14ARF-specific exon 1B may be predisposed to central nervous system tumours. We describe a family with a deletion of exon 1B in CDKN2A, who had multiple cutaneous melanomas, neural tumours and various malignancies.